augtyro - repotrectinib capsule
(Repotrectinib)E.R. Squibb & Sons, L.L.C.
Usage: Augtyro treats adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer. It also treats adults and patients aged 12+ with locally advanced or metastatic NTRK gene fusion-positive solid tumors that have progressed on prior treatment or have no satisfactory alternative therapy.